Jiangsu Hengrui Medicine
600276.SS
#429
Rank
NZ$93.62 B
Marketcap
NZ$14.11
Share price
-0.27%
Change (1 day)
31.32%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Quarterly Reports

Thumbnail Jiangsu Hengrui Medicine
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: Chinese

View Quarterly Report